|
KMID : 0911820230240010017
|
|
Korean Journal of Headache
2023 Volume.24 No. 1 p.17 ~ p.19
|
|
|
Zavegepant: Intranasal Drug for Acute Migraine Treatment
|
|
Seo Jong-Geun
|
|
|
Abstract
|
|
|
|
Calcitonin gene-related peptide (CGRP) is probably the most potent vasodilator in cerebral circulation. The new CGRP-targeted therapy for the treatment of acute treatment are now available for clinical practice. This review article summarized efficacy and safety of zavegepant, which is the first intranasal small molecule CGRP receptor antagonist for acute migraine treatment.
|
|
|
KEYWORD
|
|
|
Calcitonin gene-related peptide, Migraine, Zavegepant
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|